Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.1 USD | +3.29% | +4.91% | +41.38% |
30/04 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
29/04 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+41.38% | 559M | |
-2.47% | 89.37B | |
+2.76% | 40.65B | |
-13.51% | 32.81B | |
+51.20% | 25B | |
-16.65% | 15.29B | |
-42.60% | 11.61B | |
-12.82% | 11.49B | |
+5.62% | 8.98B | |
-7.72% | 8.23B |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- RBC Cuts Price Target on Avid Bioservices to $15 From $17 Amid 'Mixed' Fiscal Q1 Results, Keeps Outperform Rating